Register for our free email digests:
Tom Gallen
Managing Editor – Europe
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Tom Gallen
Bayer Hit With Fine For Ads Targeting Kids In Hungary
GSK Launches OTC Fluticasone In Japan Following Switch
GSK has launched Flunase in Japan following the switch of fluticasone propionate. JSMI’s Toshi Tominaga gives his assessment of the product’s prospects as an OTC drug.
Stada’s Acquisition Spree Continues With Deal For Ukrainian Probiotics Player
Sore Throat Drugs Heading Behind The Counter In France Over Safety Fears
Australia Suspends 23 Ranitdine Products Contaminated with NDMA
A six-month suspension from sale has been handed to 23 ranitidine drugs sold in Australia. The country's regulator has suggested all 23 are facing a permanent ban over patient safety fears.
Risk Vs Reward: Understanding The Africa Growth Opportunity
Africa represents a new frontier for health and beauty firms. With significant economic growth and a population explosion forecast for the continent, now is the perfect time to start thinking about the Africa opportunity, market expert Ben Longman told the recent Ceuta International Conference.